Publications by authors named "Harm-Henning Lindhof"
Article Synopsis
- - Immune checkpoint inhibitors (ICIs) are important in cancer treatment but can cause immune-related adverse events (irAEs), with musculoskeletal issues being less common but impactful.
- - The mechanisms of these musculoskeletal irAEs are not well understood, and there are no clear treatment guidelines beyond using glucocorticosteroids.
- - In the case of a 72-year-old patient with severe ICI-induced polyarthritis unresponsive to glucocorticosteroids, treatment with the IL-17A/F/AF-inhibitor bimekizumab resulted in complete clinical and sonographic recovery.
